NCT03177720View on ClinicalTrials.gov

Evaluation of Innovative Tools in Development of Antibiotics

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 29, 2016

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Pneumonia
Interventions
DRUG

Ciprofloxacin

Ciprofloxacin 400mg will be administered as single dose infusion over 60 minutes, imipenem/cilastatin 1000mg as single intravenous dose applicated over 60 minutes.

DRUG

Imipenem

Ciprofloxacin 400mg will be administered as single dose infusion over 60 minutes, imipenem/cilastatin 1000mg as single intravenous dose applicated over 60 minutes.

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03177720 - Evaluation of Innovative Tools in Development of Antibiotics | Biotech Hunter | Biotech Hunter